

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.69158263 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.44663255 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.44663255 |
| 4 | negative regulation of cell killing (GO:0031342) | 6.02216938 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.02216938 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.76819193 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.56315623 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.34271624 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.34271624 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.34271624 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.34271624 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.34271624 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 5.28900129 |
| 14 | positive thymic T cell selection (GO:0045059) | 5.19511722 |
| 15 | detection of other organism (GO:0098543) | 5.06985919 |
| 16 | detection of bacterium (GO:0016045) | 4.99193184 |
| 17 | negative T cell selection (GO:0043383) | 4.85353641 |
| 18 | leukocyte aggregation (GO:0070486) | 4.83340475 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.70045787 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.69607961 |
| 21 | negative thymic T cell selection (GO:0045060) | 4.69359024 |
| 22 | response to peptidoglycan (GO:0032494) | 4.51761971 |
| 23 | positive T cell selection (GO:0043368) | 4.49925652 |
| 24 | response to interleukin-15 (GO:0070672) | 4.48139845 |
| 25 | thymic T cell selection (GO:0045061) | 4.41603633 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.38572656 |
| 27 | T cell migration (GO:0072678) | 4.32426127 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.31926493 |
| 29 | interferon-gamma production (GO:0032609) | 4.29537044 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12485115 |
| 31 | detection of external biotic stimulus (GO:0098581) | 4.11667665 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.08627235 |
| 33 | T cell selection (GO:0045058) | 4.08230402 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01919763 |
| 35 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.86189678 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.82291503 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.81345423 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.80291477 |
| 39 | cellular extravasation (GO:0045123) | 3.80211075 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.79900068 |
| 41 | activated T cell proliferation (GO:0050798) | 3.78964911 |
| 42 | response to host immune response (GO:0052572) | 3.71048697 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.71048697 |
| 44 | leukocyte cell-cell adhesion (GO:0007159) | 3.67576948 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.66679955 |
| 46 | respiratory burst (GO:0045730) | 3.65754227 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.61039437 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.60384277 |
| 49 | detection of biotic stimulus (GO:0009595) | 3.60279131 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54575352 |
| 51 | positive regulation of histone deacetylation (GO:0031065) | 3.53527710 |
| 52 | response to host (GO:0075136) | 3.52815398 |
| 53 | response to host defenses (GO:0052200) | 3.52815398 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.52815398 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.49565068 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.42135125 |
| 57 | tolerance induction (GO:0002507) | 3.41225283 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.39354788 |
| 59 | granulocyte activation (GO:0036230) | 3.37183560 |
| 60 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.32339732 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.31149723 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27500993 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.25221781 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24533249 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.23046503 |
| 66 | negative regulation of phagocytosis (GO:0050765) | 3.22226319 |
| 67 | T cell homeostasis (GO:0043029) | 3.20374143 |
| 68 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.20094185 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19685903 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.18423896 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.18423896 |
| 72 | mannose metabolic process (GO:0006013) | 3.14960682 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.13655240 |
| 74 | positive regulation of isotype switching (GO:0045830) | 3.12280800 |
| 75 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11741962 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11213188 |
| 77 | macrophage activation (GO:0042116) | 3.10562963 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10051636 |
| 79 | microglial cell activation (GO:0001774) | 3.09496666 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07053808 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05693111 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04274508 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03569371 |
| 84 | negative regulation of interleukin-12 production (GO:0032695) | 3.03409622 |
| 85 | T cell costimulation (GO:0031295) | 3.02995552 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01714918 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.01686954 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98932771 |
| 89 | leukocyte degranulation (GO:0043299) | 2.97220317 |
| 90 | lymphocyte costimulation (GO:0031294) | 2.96346291 |
| 91 | defense response to protozoan (GO:0042832) | 2.94168490 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92392349 |
| 93 | mast cell activation (GO:0045576) | 2.91794509 |
| 94 | T cell proliferation (GO:0042098) | 2.91707976 |
| 95 | lymphocyte homeostasis (GO:0002260) | 2.91547276 |
| 96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.90128531 |
| 97 | neutrophil mediated immunity (GO:0002446) | 2.90035263 |
| 98 | negative regulation of innate immune response (GO:0045824) | 2.88878204 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.86403284 |
| 100 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85760677 |
| 101 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.83024881 |
| 102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82132229 |
| 103 | response to muramyl dipeptide (GO:0032495) | 2.81917968 |
| 104 | negative regulation of interleukin-6 production (GO:0032715) | 2.81845033 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81444249 |
| 106 | hepatocyte apoptotic process (GO:0097284) | 2.81178900 |
| 107 | definitive hemopoiesis (GO:0060216) | 2.80706658 |
| 108 | leukocyte tethering or rolling (GO:0050901) | 2.78293145 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.77792244 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77640408 |
| 111 | natural killer cell activation (GO:0030101) | 2.77458257 |
| 112 | regulation of mast cell activation (GO:0033003) | 2.76366441 |
| 113 | B cell mediated immunity (GO:0019724) | 2.75819931 |
| 114 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.74888673 |
| 115 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.74888673 |
| 116 | natural killer cell differentiation (GO:0001779) | 2.74766866 |
| 117 | positive regulation of protein deacetylation (GO:0090312) | 2.74432918 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.73838772 |
| 119 | lymphocyte migration (GO:0072676) | 2.73733816 |
| 120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73357727 |
| 121 | mature B cell differentiation (GO:0002335) | 2.72632230 |
| 122 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.71062867 |
| 123 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.68256541 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 2.65706210 |
| 125 | mast cell degranulation (GO:0043303) | 2.63872928 |
| 126 | mast cell activation involved in immune response (GO:0002279) | 2.63872928 |
| 127 | neutrophil activation (GO:0042119) | 2.62607001 |
| 128 | response to protozoan (GO:0001562) | 2.61991484 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 2.61852294 |
| 130 | response to type I interferon (GO:0034340) | 2.60781687 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60703575 |
| 132 | lymph node development (GO:0048535) | 2.60599240 |
| 133 | leukocyte homeostasis (GO:0001776) | 2.59132906 |
| 134 | defense response to fungus (GO:0050832) | 2.59021471 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57978460 |
| 136 | positive regulation of B cell mediated immunity (GO:0002714) | 2.57358548 |
| 137 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.57358548 |
| 138 | heterotypic cell-cell adhesion (GO:0034113) | 2.57352938 |
| 139 | positive regulation of interleukin-2 production (GO:0032743) | 2.56993775 |
| 140 | adaptation of signaling pathway (GO:0023058) | 2.54718139 |
| 141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.54664809 |
| 142 | B cell homeostasis (GO:0001782) | 2.54193017 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.54158109 |
| 144 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52056754 |
| 145 | cellular defense response (GO:0006968) | 2.51881514 |
| 146 | germinal center formation (GO:0002467) | 2.51236743 |
| 147 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.50694975 |
| 148 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.50457267 |
| 149 | Peyers patch development (GO:0048541) | 2.50457267 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.49811736 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.49811736 |
| 152 | response to laminar fluid shear stress (GO:0034616) | 2.49204108 |
| 153 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.48850211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.31551201 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80953158 |
| 3 | * MYC_22102868_ChIP-Seq_BL_Human | 3.62471834 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.57519089 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31599499 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31490445 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.21572726 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.11460687 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03362323 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69689323 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65868809 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.60511162 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.59084813 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.57247887 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.52922633 |
| 16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.51197022 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51111256 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46072505 |
| 19 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44668237 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.43907302 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40975621 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.39404847 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37247790 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34386778 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.28547905 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23610583 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19949587 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19165263 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17616828 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16358930 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15142328 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13404651 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.10088705 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06355657 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02400597 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.01341472 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98366576 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94831687 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89832518 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86845010 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83414514 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76325420 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70179683 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.69989471 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64488456 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61715281 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61144785 |
| 48 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57571489 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53187760 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52884358 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48285859 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39817428 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39610038 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38903668 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36827075 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36462636 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36211627 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35197540 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32361664 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30172153 |
| 61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.29978879 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28417159 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27217303 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25555433 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25119820 |
| 66 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23929210 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21871277 |
| 68 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.21593451 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19078523 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16111635 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15821648 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14715100 |
| 73 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14713437 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12879764 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12223649 |
| 76 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11663726 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10259055 |
| 78 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09320130 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08825614 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08608073 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 1.08549861 |
| 82 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06450527 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06319906 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05796098 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03936093 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03360391 |
| 87 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02934768 |
| 88 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.00996707 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00207246 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99831276 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99525084 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97954976 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97535460 |
| 94 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97065796 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96393052 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96156530 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95972441 |
| 98 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95969179 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95623241 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93756845 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93174392 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93077103 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90808152 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90163920 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87779946 |
| 106 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87668407 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84273536 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84232825 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84085662 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83383963 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83233506 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81967200 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80757513 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80635685 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80287069 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79097606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.10791935 |
| 2 | MP0005671_abnormal_response_to | 3.02207578 |
| 3 | MP0000685_abnormal_immune_system | 3.00817146 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.93064538 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.85728256 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.81257851 |
| 7 | MP0003436_decreased_susceptibility_to | 2.80362943 |
| 8 | MP0001800_abnormal_humoral_immune | 2.70405364 |
| 9 | MP0005387_immune_system_phenotype | 2.54176818 |
| 10 | MP0001790_abnormal_immune_system | 2.54176818 |
| 11 | MP0009278_abnormal_bone_marrow | 2.49801535 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.46391563 |
| 13 | MP0003303_peritoneal_inflammation | 2.46013810 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.45487880 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.40161661 |
| 16 | MP0001819_abnormal_immune_cell | 2.37516365 |
| 17 | MP0002398_abnormal_bone_marrow | 2.36083601 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.35082833 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.34871349 |
| 20 | MP0005025_abnormal_response_to | 2.34637005 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.31413805 |
| 22 | MP0002723_abnormal_immune_serum | 2.31378736 |
| 23 | MP0001873_stomach_inflammation | 2.30338744 |
| 24 | MP0009785_altered_susceptibility_to | 2.25490340 |
| 25 | MP0008260_abnormal_autophagy | 2.25183916 |
| 26 | MP0004947_skin_inflammation | 2.18182613 |
| 27 | MP0002419_abnormal_innate_immunity | 2.14649566 |
| 28 | MP0000716_abnormal_immune_system | 2.06528496 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.06177596 |
| 30 | MP0002405_respiratory_system_inflammati | 2.03870926 |
| 31 | MP0005451_abnormal_body_composition | 2.00976142 |
| 32 | MP0003866_abnormal_defecation | 1.98041725 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.97992929 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.97498655 |
| 35 | MP0002722_abnormal_immune_system | 1.97006313 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.94464071 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.94464071 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.91822440 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.90165482 |
| 40 | MP0002006_tumorigenesis | 1.89214324 |
| 41 | MP0006082_CNS_inflammation | 1.84171403 |
| 42 | MP0002429_abnormal_blood_cell | 1.75621055 |
| 43 | MP0004381_abnormal_hair_follicle | 1.75557190 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.66915012 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.66823198 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.63394629 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.58459084 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.54501770 |
| 49 | MP0003724_increased_susceptibility_to | 1.50144633 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.47926438 |
| 51 | MP0001853_heart_inflammation | 1.45985100 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.43526341 |
| 53 | MP0000858_altered_metastatic_potential | 1.40135651 |
| 54 | MP0000490_abnormal_crypts_of | 1.38153945 |
| 55 | MP0004510_myositis | 1.35986469 |
| 56 | MP0002933_joint_inflammation | 1.33250706 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.29191872 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.28966051 |
| 59 | MP0003448_altered_tumor_morphology | 1.26080905 |
| 60 | MP0005310_abnormal_salivary_gland | 1.25652799 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.21951049 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.21496559 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.21149735 |
| 64 | MP0010307_abnormal_tumor_latency | 1.21070012 |
| 65 | MP0001851_eye_inflammation | 1.18914055 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.18894283 |
| 67 | MP0004883_abnormal_blood_vessel | 1.18649711 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.18191932 |
| 69 | MP0008469_abnormal_protein_level | 1.17003244 |
| 70 | MP0005023_abnormal_wound_healing | 1.09246925 |
| 71 | MP0002009_preneoplasia | 1.06015346 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.00420306 |
| 73 | MP0009840_abnormal_foam_cell | 0.94038248 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.92646827 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.92357355 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.91864606 |
| 77 | MP0009764_decreased_sensitivity_to | 0.89465122 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 0.89457958 |
| 79 | MP0008004_abnormal_stomach_pH | 0.86898616 |
| 80 | MP0002796_impaired_skin_barrier | 0.85096490 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.83746315 |
| 82 | MP0003045_fibrosis | 0.83383418 |
| 83 | MP0005164_abnormal_response_to | 0.82973204 |
| 84 | MP0003690_abnormal_glial_cell | 0.80334682 |
| 85 | MP0002132_abnormal_respiratory_system | 0.78647508 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.78570488 |
| 87 | MP0003828_pulmonary_edema | 0.78520136 |
| 88 | MP0005390_skeleton_phenotype | 0.78143798 |
| 89 | MP0000343_altered_response_to | 0.77706134 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.76183150 |
| 91 | MP0009763_increased_sensitivity_to | 0.74413150 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.70934261 |
| 93 | MP0002928_abnormal_bile_duct | 0.70902723 |
| 94 | MP0005166_decreased_susceptibility_to | 0.70322598 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.70286497 |
| 96 | MP0001663_abnormal_digestive_system | 0.69294568 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.69036327 |
| 98 | MP0000609_abnormal_liver_physiology | 0.68507461 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.67327054 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.66605963 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.65769730 |
| 102 | MP0005083_abnormal_biliary_tract | 0.65700499 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.65374626 |
| 104 | MP0003795_abnormal_bone_structure | 0.64489665 |
| 105 | MP0000371_diluted_coat_color | 0.64093863 |
| 106 | MP0005409_darkened_coat_color | 0.63347233 |
| 107 | MP0006054_spinal_hemorrhage | 0.63094761 |
| 108 | MP0009931_abnormal_skin_appearance | 0.62452362 |
| 109 | MP0001849_ear_inflammation | 0.62412486 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.61683381 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.60108755 |
| 112 | MP0001191_abnormal_skin_condition | 0.60005688 |
| 113 | MP0000249_abnormal_blood_vessel | 0.59957596 |
| 114 | MP0003075_altered_response_to | 0.58804516 |
| 115 | MP0003091_abnormal_cell_migration | 0.58798519 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.57648680 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.57568104 |
| 118 | MP0008874_decreased_physiological_sensi | 0.56787558 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55314230 |
| 120 | MP0000598_abnormal_liver_morphology | 0.54998738 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.54842459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.60562066 |
| 2 | T lymphocytopenia (HP:0005403) | 4.29786757 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.29742409 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.26238551 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12708389 |
| 6 | Recurrent viral infections (HP:0004429) | 4.12087907 |
| 7 | Nasal polyposis (HP:0100582) | 4.09123888 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.03120989 |
| 9 | Pustule (HP:0200039) | 4.01236005 |
| 10 | IgM deficiency (HP:0002850) | 3.90085072 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.83839778 |
| 12 | Chronic otitis media (HP:0000389) | 3.83565285 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.78531692 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.75648041 |
| 15 | Myositis (HP:0100614) | 3.71881134 |
| 16 | Abnormality of the fingertips (HP:0001211) | 3.68902756 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.65182987 |
| 18 | Abnormality of T cells (HP:0002843) | 3.50452154 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.47219517 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.42898631 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38767595 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.31509479 |
| 23 | Increased IgE level (HP:0003212) | 3.21383609 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.18370108 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16869011 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16869011 |
| 27 | Urticaria (HP:0001025) | 3.10023040 |
| 28 | Meningitis (HP:0001287) | 3.04745804 |
| 29 | Recurrent bronchitis (HP:0002837) | 3.04681473 |
| 30 | Colitis (HP:0002583) | 3.02002798 |
| 31 | Recurrent skin infections (HP:0001581) | 2.97899873 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.91848167 |
| 33 | Hypochromic anemia (HP:0001931) | 2.90310125 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88392174 |
| 35 | Thrombocytosis (HP:0001894) | 2.87823558 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.87285075 |
| 37 | Cellulitis (HP:0100658) | 2.83797574 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.82525825 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.74105725 |
| 40 | Periodontitis (HP:0000704) | 2.74088534 |
| 41 | * Prolonged bleeding time (HP:0003010) | 2.73678958 |
| 42 | Abnormal platelet volume (HP:0011876) | 2.70017207 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.69230527 |
| 44 | Petechiae (HP:0000967) | 2.63717841 |
| 45 | B lymphocytopenia (HP:0010976) | 2.59138502 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.59138502 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.58726903 |
| 48 | Papilloma (HP:0012740) | 2.57372055 |
| 49 | Verrucae (HP:0200043) | 2.57372055 |
| 50 | Gingival bleeding (HP:0000225) | 2.54885625 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.54617977 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.54145207 |
| 53 | Obstructive lung disease (HP:0006536) | 2.53060460 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53060460 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.52265408 |
| 56 | Arterial thrombosis (HP:0004420) | 2.47306800 |
| 57 | * Epistaxis (HP:0000421) | 2.44860732 |
| 58 | Leukocytosis (HP:0001974) | 2.44738702 |
| 59 | Eosinophilia (HP:0001880) | 2.44671978 |
| 60 | Thyroiditis (HP:0100646) | 2.44150632 |
| 61 | Gingivitis (HP:0000230) | 2.41587112 |
| 62 | Hematochezia (HP:0002573) | 2.40900826 |
| 63 | Orchitis (HP:0100796) | 2.39819133 |
| 64 | Vasculitis (HP:0002633) | 2.39150879 |
| 65 | Episodic fever (HP:0001954) | 2.38984456 |
| 66 | Chest pain (HP:0100749) | 2.37761859 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.36292328 |
| 68 | Stomatitis (HP:0010280) | 2.36216498 |
| 69 | Granulocytopenia (HP:0001913) | 2.30741882 |
| 70 | Lymphopenia (HP:0001888) | 2.29861705 |
| 71 | Sepsis (HP:0100806) | 2.27751907 |
| 72 | Increased IgM level (HP:0003496) | 2.25619735 |
| 73 | Viral hepatitis (HP:0006562) | 2.24589688 |
| 74 | Anorexia (HP:0002039) | 2.24521825 |
| 75 | Increased density of long bones (HP:0006392) | 2.24334664 |
| 76 | Increased mean platelet volume (HP:0011877) | 2.24203654 |
| 77 | Encephalitis (HP:0002383) | 2.23704644 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23324851 |
| 79 | Ureteral stenosis (HP:0000071) | 2.21458849 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.21022743 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.20852377 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.20374465 |
| 83 | Metaphyseal cupping (HP:0003021) | 2.19062006 |
| 84 | Hemoptysis (HP:0002105) | 2.17078305 |
| 85 | Cerebral aneurysm (HP:0004944) | 2.16648944 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.16226718 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.15402243 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.13946827 |
| 89 | Peritonitis (HP:0002586) | 2.13667463 |
| 90 | Optic neuritis (HP:0100653) | 2.12295560 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.12295560 |
| 92 | Combined immunodeficiency (HP:0005387) | 2.11301082 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.11236571 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.10049983 |
| 95 | Amyloidosis (HP:0011034) | 2.06983645 |
| 96 | Skin ulcer (HP:0200042) | 2.06890896 |
| 97 | Chronic diarrhea (HP:0002028) | 2.05964311 |
| 98 | Hyperacusis (HP:0010780) | 2.05818591 |
| 99 | Agammaglobulinemia (HP:0004432) | 2.05575977 |
| 100 | Ureteral obstruction (HP:0006000) | 2.04375221 |
| 101 | Increased serum ferritin (HP:0003281) | 1.99761345 |
| 102 | Malnutrition (HP:0004395) | 1.99728760 |
| 103 | Abnormality of the thoracic spine (HP:0100711) | 1.99221470 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 1.98618146 |
| 105 | Fatigue (HP:0012378) | 1.97988107 |
| 106 | Microcytic anemia (HP:0001935) | 1.97126251 |
| 107 | Gangrene (HP:0100758) | 1.96551065 |
| 108 | Autoimmune hemolytic anemia (HP:0001890) | 1.96483823 |
| 109 | Abnormality of the pleura (HP:0002103) | 1.96472538 |
| 110 | Joint swelling (HP:0001386) | 1.96003307 |
| 111 | Broad face (HP:0000283) | 1.95007882 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.94482784 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94482784 |
| 114 | Cheilitis (HP:0100825) | 1.94098217 |
| 115 | IgG deficiency (HP:0004315) | 1.93504348 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 1.92413449 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 1.91816891 |
| 118 | Polygenic inheritance (HP:0010982) | 1.91091890 |
| 119 | IgA deficiency (HP:0002720) | 1.90953453 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 1.88532454 |
| 121 | Basal cell carcinoma (HP:0002671) | 1.88377507 |
| 122 | Pulmonary embolism (HP:0002204) | 1.86309758 |
| 123 | Spondylolisthesis (HP:0003302) | 1.86162874 |
| 124 | Restrictive lung disease (HP:0002091) | 1.85666062 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85136388 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84429977 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84429977 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84429977 |
| 129 | Abnormality of the endocardium (HP:0004306) | 1.83349946 |
| 130 | Purpura (HP:0000979) | 1.82860705 |
| 131 | * Impaired platelet aggregation (HP:0003540) | 1.82788536 |
| 132 | * Abnormal platelet function (HP:0011869) | 1.82788536 |
| 133 | Acute myeloid leukemia (HP:0004808) | 1.82782580 |
| 134 | Bicuspid aortic valve (HP:0001647) | 1.81043331 |
| 135 | Osteomyelitis (HP:0002754) | 1.80429981 |
| 136 | Obstructive sleep apnea (HP:0002870) | 1.80192904 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.79841030 |
| 138 | Hepatosplenomegaly (HP:0001433) | 1.79533525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.82337357 |
| 2 | EEF2K | 3.25535965 |
| 3 | PRPF4B | 3.22211884 |
| 4 | PKN2 | 2.75789105 |
| 5 | TRIB3 | 2.71031785 |
| 6 | TXK | 2.58139404 |
| 7 | JAK3 | 2.47732019 |
| 8 | STK10 | 2.41997129 |
| 9 | ZAP70 | 2.35329314 |
| 10 | TYK2 | 2.18284756 |
| 11 | MAP3K10 | 2.17647863 |
| 12 | ITK | 2.15317438 |
| 13 | GRK6 | 2.07847221 |
| 14 | BTK | 1.92523601 |
| 15 | EPHB1 | 1.91412366 |
| 16 | TAOK3 | 1.86238756 |
| 17 | ERN1 | 1.81498651 |
| 18 | SMG1 | 1.75597830 |
| 19 | FGFR4 | 1.70136839 |
| 20 | TTN | 1.59462024 |
| 21 | TGFBR2 | 1.58657493 |
| 22 | LRRK2 | 1.58048499 |
| 23 | CDK12 | 1.56595747 |
| 24 | SIK2 | 1.55915671 |
| 25 | JAK1 | 1.54882141 |
| 26 | KIT | 1.51846860 |
| 27 | PTK6 | 1.50175100 |
| 28 | CSK | 1.49353480 |
| 29 | HCK | 1.45908040 |
| 30 | FES | 1.43986573 |
| 31 | IRAK4 | 1.43359713 |
| 32 | SIK3 | 1.42718620 |
| 33 | BLK | 1.42153696 |
| 34 | TEC | 1.40448550 |
| 35 | MAP2K3 | 1.38665377 |
| 36 | LCK | 1.38133574 |
| 37 | SYK | 1.34404867 |
| 38 | MAP3K13 | 1.33937480 |
| 39 | FGR | 1.32395137 |
| 40 | IKBKE | 1.31337958 |
| 41 | FGFR3 | 1.28754017 |
| 42 | TBK1 | 1.28393902 |
| 43 | CSF1R | 1.22470510 |
| 44 | FLT3 | 1.21821585 |
| 45 | MAP3K14 | 1.18793352 |
| 46 | MAP3K7 | 1.18128417 |
| 47 | CAMK1D | 1.16951874 |
| 48 | KSR2 | 1.16939897 |
| 49 | MAP3K6 | 1.13022795 |
| 50 | RIPK1 | 1.08435771 |
| 51 | CAMK1G | 1.05542980 |
| 52 | PIM1 | 0.99600892 |
| 53 | CDC42BPA | 0.99434208 |
| 54 | RPS6KA4 | 0.98947368 |
| 55 | PRKCH | 0.98730517 |
| 56 | MARK3 | 0.97170163 |
| 57 | JAK2 | 0.95182955 |
| 58 | TRPM7 | 0.94880036 |
| 59 | YES1 | 0.92998425 |
| 60 | CDK4 | 0.88732475 |
| 61 | NEK2 | 0.85854214 |
| 62 | CLK1 | 0.84185061 |
| 63 | RPS6KB2 | 0.81593206 |
| 64 | RIPK4 | 0.81090411 |
| 65 | PDPK1 | 0.80485375 |
| 66 | TAOK2 | 0.77841607 |
| 67 | TAOK1 | 0.77778221 |
| 68 | HIPK2 | 0.77609918 |
| 69 | TNK2 | 0.77263496 |
| 70 | IRAK1 | 0.77138263 |
| 71 | SIK1 | 0.76214999 |
| 72 | PAK4 | 0.74383838 |
| 73 | IRAK2 | 0.73543157 |
| 74 | MAPK12 | 0.73045783 |
| 75 | ALK | 0.72455023 |
| 76 | ICK | 0.72127892 |
| 77 | BRD4 | 0.72050876 |
| 78 | MATK | 0.70599577 |
| 79 | CDK6 | 0.70044122 |
| 80 | KDR | 0.69396326 |
| 81 | IKBKB | 0.68042666 |
| 82 | IRAK3 | 0.66436177 |
| 83 | MAPK7 | 0.65618423 |
| 84 | NLK | 0.63993265 |
| 85 | LYN | 0.61481609 |
| 86 | MAP3K2 | 0.60299436 |
| 87 | SCYL2 | 0.58625691 |
| 88 | CHUK | 0.58531922 |
| 89 | MAPKAPK3 | 0.58515711 |
| 90 | MST4 | 0.58200941 |
| 91 | PRKCQ | 0.56854300 |
| 92 | NME2 | 0.56369554 |
| 93 | FYN | 0.56187992 |
| 94 | PDGFRB | 0.55703558 |
| 95 | TGFBR1 | 0.55623424 |
| 96 | BMPR2 | 0.54854675 |
| 97 | STK4 | 0.54539627 |
| 98 | DMPK | 0.51970407 |
| 99 | TESK2 | 0.51379062 |
| 100 | MAP2K6 | 0.51068286 |
| 101 | PDK1 | 0.50123790 |
| 102 | EPHA3 | 0.48799403 |
| 103 | CDK9 | 0.48771335 |
| 104 | MAP3K8 | 0.48497766 |
| 105 | MTOR | 0.46641984 |
| 106 | RPS6KA6 | 0.46514062 |
| 107 | PASK | 0.45785859 |
| 108 | MARK2 | 0.45726338 |
| 109 | PRKD2 | 0.45141737 |
| 110 | PTK2B | 0.43314201 |
| 111 | MST1R | 0.43203318 |
| 112 | BMX | 0.42949900 |
| 113 | RPS6KL1 | 0.41730768 |
| 114 | RPS6KC1 | 0.41730768 |
| 115 | MAP3K11 | 0.40987195 |
| 116 | PTK2 | 0.40339226 |
| 117 | MAPKAPK2 | 0.40097874 |
| 118 | STK11 | 0.40050375 |
| 119 | CAMKK1 | 0.40027022 |
| 120 | SGK3 | 0.39683161 |
| 121 | MAP3K3 | 0.39229810 |
| 122 | MAP3K1 | 0.39049884 |
| 123 | MAP2K2 | 0.38622650 |
| 124 | MAPK11 | 0.38478471 |
| 125 | RPS6KA2 | 0.38144540 |
| 126 | DYRK1B | 0.36797567 |
| 127 | RET | 0.35150748 |
| 128 | STK38 | 0.34557316 |
| 129 | MAP2K4 | 0.32272309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.48930116 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50305478 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.47708648 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.37652562 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35998019 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.27453484 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21595828 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18673971 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06241854 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05751275 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.03873509 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92210746 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.88996567 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85726118 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84359593 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.82980865 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79968641 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67873074 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66461582 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63062023 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62849256 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60852527 |
| 23 | Platelet activation_Homo sapiens_hsa04611 | 1.51787583 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50051674 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46065886 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40560285 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33988423 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31544804 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31160779 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31097876 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.30232462 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29500640 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26879915 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.23268993 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.23239152 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.22491886 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21903105 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.21700292 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20600547 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18161735 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16617143 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16563116 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12642079 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.10624240 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08039861 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07884207 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06598242 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02820296 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01668198 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 1.00995574 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.00530422 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99612299 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.98792666 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.97880557 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96641479 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95443578 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.92283954 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.91619817 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90639951 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.90088453 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88892055 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87323271 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86005203 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82839290 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80941555 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75850095 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.75688411 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75440096 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.75343588 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74689620 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74414575 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.70663054 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69374828 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69223702 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69206260 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66588555 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66222359 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65805271 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62100238 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61325420 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61269751 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60522595 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60031526 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.59040728 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58854901 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58716957 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58020616 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.57966138 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.56782292 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54844627 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54794116 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.54218663 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53537731 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53421117 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52508604 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52451562 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.51721528 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51155692 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50456596 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50011859 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49727855 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49469617 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.47940423 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47534807 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45335029 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.45251291 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42775629 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42546248 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40412509 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40258959 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39025586 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38872136 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.38789328 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38541933 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35828144 |

